- Home
- VMAR vs PHIO Comparison
VMAR vs PHIO Comparison
Compare VMAR & PHIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VMAR
- PHIO
- Stock Information
- Founded
- VMAR 1995
- PHIO 2011
- Country
- VMAR Canada
- PHIO United States
- Employees
- VMAR N/A
- PHIO N/A
- Industry
- VMAR Marine Transportation
- PHIO Biotechnology: Pharmaceutical Preparations
- Sector
- VMAR Industrials
- PHIO Health Care
- Exchange
- VMAR Nasdaq
- PHIO Nasdaq
- Market Cap
- VMAR 2.5M
- PHIO 2.3M
- IPO Year
- VMAR 2020
- PHIO N/A
- Fundamental
- Price
- VMAR $2.76
- PHIO $2.21
- Analyst Decision
- VMAR Strong Buy
- PHIO Strong Buy
- Analyst Count
- VMAR 1
- PHIO 1
- Target Price
- VMAR $270.00
- PHIO $36.00
- AVG Volume (30 Days)
- VMAR 1.3M
- PHIO 41.4K
- Earning Date
- VMAR 01-14-2025
- PHIO 11-14-2024
- Dividend Yield
- VMAR N/A
- PHIO N/A
- EPS Growth
- VMAR N/A
- PHIO N/A
- EPS
- VMAR N/A
- PHIO N/A
- Revenue
- VMAR $3,588,257.00
- PHIO N/A
- Revenue This Year
- VMAR N/A
- PHIO N/A
- Revenue Next Year
- VMAR $115.79
- PHIO N/A
- P/E Ratio
- VMAR N/A
- PHIO N/A
- Revenue Growth
- VMAR N/A
- PHIO N/A
- 52 Week Low
- VMAR $2.69
- PHIO $2.17
- 52 Week High
- VMAR $272.70
- PHIO $18.81
- Technical
- Relative Strength Index (RSI)
- VMAR 27.85
- PHIO 32.01
- Support Level
- VMAR $2.76
- PHIO $2.49
- Resistance Level
- VMAR $3.01
- PHIO $3.70
- Average True Range (ATR)
- VMAR 0.33
- PHIO 0.31
- MACD
- VMAR 0.33
- PHIO -0.10
- Stochastic Oscillator
- VMAR 0.00
- PHIO 2.75
About VMAR Vision Marine Technologies Inc.
Vision Marine Technologies Inc is in the business of designing and manufacturing electric outboard powertrain systems, power boats, and related technology and the renting of electric boats. The different models of the powerboats and electric boats manufactured by the company includes, Bruce 22, Fantail 217, Volt 180 and others. The company operates in two reportable business segments; Sale of electric boats and Rental of electric boats. The majority of the revenue for the company is generated from its Rental of electric boats segment. Geographically, the company generates revenue from its business in Canada, USA and other countries. A substantial portion of the overall revenue is generated from its business in USA.
About PHIO Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.